Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Researchers compared ABT-126 and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimResearchers compared ER OROS paliperidone, placebo and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Aizu-WakamatsuA Phase III, Multi-Center, Randomized, 24 Week, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate Efficacy and Safety of RO4917838 in Stable Patients With Persistent, Predominant Negative Symptoms of Schizophrenia Treated With Antipsychotics Followed by a 28 Week, Double-Blind Treatment Period
This study has finished and is no longer accepting participants.
Multiple locations, including Costa MesaAn Open Label, Prospective, Non-Comparative Study to Evaluate Flexible Dose of Paliperidone ER and Clinical Response in the Treatment of Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedA Study to Evaluate Switching From Risperidone to Paliperidone ER (Extended Release) in the Treatment of Stable But Symptomatic Schizophrenia Outpatients: Patients Satisfaction and Quality of Life
This study has finished and is no longer accepting participants.
Multiple locations, including Belo HorizonteA Prospective, Open-Label Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres (Risperdal Consta)
This study has finished and is no longer accepting participants.
Location not clearly listedA Pilot-Study in Rwandan Health Care Settings to Examine the Feasibility of a Large Pragmatic Clinical Study to Assess the Value of Paliperidone Palmitate in Rwanda
This study has finished and is no longer accepting participants.
Multiple locations, including KigaliA Randomized, Open-Label, Study To Evaluate The Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Selected Cognitive Domains in Clinically Stable Subjects With Schizophrenia
This study ended early.
Multiple locations, including Bali Township, Taipei CountyThis study evaluated the safety and effectiveness of paliperidone palmitate for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety and effectiveness of Basmisanil for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA 12 Week, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveA Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.